These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33583810)

  • 1. Emerging pharmacy services; Recommendations for emergency care of COVID-19 pandemic in low and middle-income countries.
    Hamid H; Masood RA; Khalid W; Saqlain M; Tariq H; Munir MU
    Pak J Pharm Sci; 2020 Jul; 33(4):1735-1738. PubMed ID: 33583810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 Pandemic.
    Ghibu S; Juncan AM; Rus LL; Frum A; Dobrea CM; Chiş AA; Gligor FG; Morgovan C
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries.
    Paudyal V; Cadogan C; Fialová D; Henman MC; Hazen A; Okuyan B; Lutters M; Stewart D
    Res Social Adm Pharm; 2021 Aug; 17(8):1507-1517. PubMed ID: 33288420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.
    Zheng SQ; Yang L; Zhou PX; Li HB; Liu F; Zhao RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1819-1824. PubMed ID: 32249102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' Preparedness to Patients Education at the Time of Pandemic-A Cross-Sectional Study with an Example of SARS-CoV-2 Outbreak in Poland.
    Cerbin-Koczorowska M; Waszyk-Nowaczyk M; Przymuszała P
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32932684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Management of the Public and Patients by Pharmacists in the Era of COVID-19: An Evidence-Based Review and Practical Recommendations.
    Song Z; Hu Y; Ren Z; Wang G; Liu S; Zheng S; Yang L; Zhao R
    Front Public Health; 2021; 9():758325. PubMed ID: 35087781
    [No Abstract]   [Full Text] [Related]  

  • 8. Community pharmacy during the COVID-19 pandemic: a cross-sectional study.
    Merks P; Świeczkowski D; Bilmin K; Jakubowska M; Drelich E; Lewicki J; Gołębiewska W; Bogusz J; Jaguszewski M
    Przegl Epidemiol; 2020; 74(4):620-633. PubMed ID: 33861029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationship between Customers and Community Pharmacies during the COVID-19 (SARS-CoV-2) Pandemic: A Survey from Italy.
    Baratta F; Ciccolella M; Brusa P
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Providing pharmacy services during the coronavirus pandemic.
    Liu S; Luo P; Tang M; Hu Q; Polidoro JP; Sun S; Gong Z
    Int J Clin Pharm; 2020 Apr; 42(2):299-304. PubMed ID: 32222911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to the first wave of the COVID-19 pandemic in the community pharmacy of a University Center for Primary Care and Public Health.
    Bourdin A; Dotta-Celio J; Niquille A; Berger J
    Res Social Adm Pharm; 2022 Apr; 18(4):2706-2710. PubMed ID: 34154930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coping strategies of community pharmacists and pharmaceutical services provided during COVID-19 in Malaysia.
    Kua KP; Lee SWH
    Int J Clin Pract; 2021 Dec; 75(12):e14992. PubMed ID: 34710264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Readiness and Willingness to Provide Immunization Services after Pilot Vaccination Training: A Survey among Community Pharmacists Trained and Not Trained in Immunization during the COVID-19 Pandemic in Poland.
    Merks P; Religioni U; Bilmin K; Lewicki J; Jakubowska M; Waksmundzka-Walczuk A; Czerw A; Barańska A; Bogusz J; Plagens-Rotman K; Świetlik D; Drelich E; Świeczkowski D; Lambert J; Jaguszewski M; Juszczyk G; Balkhi B; Vaillancourt R
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33445750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community Pharmacists Roles During the COVID-19 Pandemic.
    Hess K; Bach A; Won K; Seed SM
    J Pharm Pract; 2022 Jun; 35(3):469-476. PubMed ID: 33317371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic preparedness of community pharmacies for COVID-19.
    Bahlol M; Dewey RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1888-1896. PubMed ID: 32417070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacy interventions on COVID-19 in Europe: Mapping current practices and a scoping review.
    Costa S; Romão M; Mendes M; Horta MR; Rodrigues AT; Carneiro AV; Martins AP; Mallarini E; Naci H; Babar ZU
    Res Social Adm Pharm; 2022 Aug; 18(8):3338-3349. PubMed ID: 34924315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing clinical pharmacist telehealth services during the COVID-19 pandemic.
    Segal EM; Alwan L; Pitney C; Taketa C; Indorf A; Held L; Lee KS; Son M; Chi M; Diamantides E; Gosser R
    Am J Health Syst Pharm; 2020 Aug; 77(17):1403-1408. PubMed ID: 34279578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward.
    Mallhi TH; Liaqat A; Abid A; Khan YH; Alotaibi NH; Alzarea AI; Tanveer N; Khan TM
    Front Public Health; 2020; 8():561924. PubMed ID: 33364224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provision of pharmaceutical care to suspected high-risk COVID-19 patients through telehealth: a nationwide simulated patient study.
    Itani R; Khojah HMJ; Jaffal F; Rahme D; Karout L; Karout S
    BMC Health Serv Res; 2021 Sep; 21(1):997. PubMed ID: 34548092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.